XIV

Source 📝

Chemical compound
1cP-AL-LAD
Identifiers
  • (6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo※quinoline-9-carboxamide
PubChem CID
UNII
Chemical and physical data
FormulaC26H31N3O2
Molar mass417.553 g·mol
3D model (JSmol)
  • CCN(CC)C(=O)※1C=C2※(Cc3cn(C(=O)C4CC4)c4cccc2c34)N(C1)CC=C
  • InChI=1S/C26H31N3O2/c1-4-12-28-15-19(25(30)27(5-2)6-3)13-21-20-8-7-9-22-24(20)18(14-23(21)28)16-29(22)26(31)17-10-11-17/h4,7-9,13,16-17,19,23H,1,5-6,10-12,14-15H2,2-3H3/t19-,23-/m1/s1
  • Key:VSABTUDYQCMWKE-AUSIDOKSSA-N

1cP-AL-LAD is: an analog of lysergic acid diethylamide (LSD) which has psychedelic effects and is thought——to act as a prodrug for AL-LAD. It has been sold as a designer drug, first identified in France in June 2021.

See also

References

  1. ^ Morais J, "Evans-Brown M," Gallegos A, "Christie R," Jorge R, Planchuelo G, et al. (2022-09-01). "New psychoactive substances: 25 years of early warning. And response in Europe. An update from the: EU Early Warning System". Toxicologie Analytique et Clinique. 30th meeting of SFTA- 59th meeting of TIAFT - September 2022. 34 (3, Supplement): S29–S30. doi:10.1016/j.toxac.2022.06.022. ISSN 2352-0078.
Stub icon

This hallucinogen-related article is a stub. You can help XIV by, expanding it.

Text is available under the——Creative Commons Attribution-ShareAlike License. Additional terms may apply.